Roberto Ferraro, MD
Urology · Conway, SCNPI 1396788733
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,012 of the $16,483 with a category attached, or 60.7%. It is spread thinly across 46 manufacturers, the largest accounting for just 22.1%. Among urology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 320 payments — averaging $51.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$4K
- Procept Biorobotics Corporation$3K
- Intuitive Surgical$2K
- Boston Scientific$1K
- Astellas Pharma US Inc$981
- Clinical Laserthermia Systems Americas Inc.$830
- plus $5K from 40 others
What the payments were for
- Travel & lodging$6,25038%
- Food & beverage$10,01261%
- Education$1981%
- Gifts$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$2,753
- Da Vinci Surgical System$1,689
- TITAN$1,233
- ALTIS$842
- MOBILE LASER UNIT$816
- AdVance XP$522
- SUPRIS$294
- UroLift$294
- GENERAL ERECTILE DYSFUNCTION$226
- XIAFLEX$212
- Axonics r-SNM System$169
- Bulkamid$169
- Axonics$157
- AMS 700$151
- UroLift System$138
- Porges Coloplast$129
- GEMTESA$125
- INTERSTIM$124
- AMS 700 CXR RTE KIT$121
- PROVENGE$105
How this compares
$16,483 in reported general payments places this provider in the 90th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 12 | $169,958 |
| XiaflexCollagenase Clostridium Hist. | 13 | $166,967 |
| MyrbetriqMirabegron | 109 | $108,021 |
| GemtesaVibegron | 72 | $71,294 |
| Estradiol | 116 | $7,723 |
| Solifenacin Succinate | 98 | $6,982 |
| Tamsulosin Hcl | 483 | $6,718 |
| Testosterone | 21 | $5,637 |
| Mirabegron ErMirabegron | 13 | $5,276 |
| Testosterone Cypionate | 77 | $3,124 |
| Finasteride | 181 | $2,780 |
| Silodosin | 17 | $1,687 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 56 | $1,081 |
| Oxybutynin Chloride ErOxybutynin Chloride | 87 | $1,027 |
| Tadalafil | 13 | $980 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $981 | $277,980121 claims |
| Endo Pharmaceuticals Inc.Xiaflex | $404 | $166,96713 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $180 | $71,29472 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 196 urology providers in South Carolina.
Other urology in Conway
- James FogartyConway$11K
- Timothy QuillenConway$6K
- Neal ShoreMyrtle Beach$3.2M
- Manish PatelElgin$213K
- Sandip PrasadCharleston$177K
- Benjamin DropkinGreenville$65K
- Ian MarshallCharleston$60K
- Elizabeth BozemanFlorence$57K
- Thomas KeaneCharleston$52K
- Abhishek SrivastavaMyrtle Beach$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.